[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Vemula H., Villanueva F.S., Nguyen H.D., Mohan A., Potluri S
Current users are about twice as likely to be obese as those who have never taken injections (71% vs
Tirzepatide is a newer medication designed to help with weight management
Regular check-ins with your healthcare provider ensure that the treatment remains effective and tailored to your ongoing needs
In the SURMOUNT-5 trial, published in the New England Journal of Medicine, patients receiving tirzepatide had a mean percent decrease in body weight of 20.2%, compared with 13.7% for those receiving semaglutide,over 72 weeks
Weeks 36 Hunger often becomes more consistent and manageable